B-cell non-Hodgkin lymphomas.
Silkenstedt E, Salles G, Campo E, Dreyling M.
Lancet. 2024 May 4;403(10438):1791-1807. doi: 10.1016/S0140-6736(23)02705-8. Epub 2024 Apr 10.
B Cell Lymphoma.
Meng X, Min Q, Wang JY.
Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12.
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Falini B, Martino G, Lazzi S.
Leukemia. 2023 Jan;37(1):18-34. doi: 10.1038/s41375-022-01764-1. Epub 2022 Dec 2.
Gastrointestinal non-Hodgkin lymphomas.
Olszewska-Szopa M, Wróbel T.
Adv Clin Exp Med. 2019 Aug;28(8):1119-1124. doi: 10.17219/acem/94068.
[B-cell lymphomas].
Ennishi D.
Rinsho Ketsueki. 2019;60(5):434-440. doi: 10.11406/rinketsu.60.434.
Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S, Dammeijer F, Hendriks RW.
Mol Cancer. 2018 Feb 19;17(1):57. doi: 10.1186/s12943-018-0779-z.
Burkitt lymphoma.
Fang H, Wang W, Medeiros LJ.
Hum Pathol. 2025 Feb;156:105703. doi: 10.1016/j.humpath.2024.105703. Epub 2024 Dec 9.
Neurotrophins and B-cell malignancies.
Hillis J, O'Dwyer M, Gorman AM.
Cell Mol Life Sci. 2016 Jan;73(1):41-56. doi: 10.1007/s00018-015-2046-4. Epub 2015 Sep 23.
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).
Hilton LK, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng AP, Cruz M, Slack GW, Farinha P, Miyata-Takata T, Boyle M, Meissner B, Cook JR, Ondrejka SL, Ott G, Rosenwald A, Campo E, Amador C, Greiner TC, Raess PW, Song JY, Inghirami G, Jaffe ES, Weisenburger DD, Chan WC, Beiske K, Fu K, Delabie J, Pittaluga S, Iqbal J, Wright G, Sehn LH, Savage KJ, Mungall AJ, Feldman AL, Staudt LM, Steidl C, Rimsza LM, Morin RD, Scott DW.
Blood. 2024 Aug 1;144(5):525-540. doi: 10.1182/blood.2024024251.
Calcium-dependent signalling in B-cell lymphomas.
Berditchevski F, Fennell E, Murray PG.
Oncogene. 2021 Nov;40(45):6321-6328. doi: 10.1038/s41388-021-02025-8. Epub 2021 Oct 8.
